Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0F4UT
|
|||
Former ID |
DNC009964
|
|||
Drug Name |
2-(2-(biphenyl-4-yl)ethylsulfinyl)acetic acid
|
|||
Synonyms |
CHEMBL572947; 2-(2-(biphenyl-4-yl)ethylsulfinyl)acetic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H16O3S
|
|||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)CCS(=O)CC(=O)O
|
|||
InChI |
1S/C16H16O3S/c17-16(18)12-20(19)11-10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9H,10-12H2,(H,17,18)
|
|||
InChIKey |
JPUWBNMOSGBVRW-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Matrix metalloproteinase-12 (MMP-12) | Target Info | Inhibitor | [1] |
NetPath Pathway | IL1 Signaling Pathway | |||
IL5 Signaling Pathway | ||||
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||
Reactome | Collagen degradation | |||
Degradation of the extracellular matrix | ||||
WikiPathways | TGF beta Signaling Pathway | |||
Degradation of collagen | ||||
Matrix Metalloproteinases |
References | Top | |||
---|---|---|---|---|
REF 1 | The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors. Bioorg Med Chem Lett. 2009 Oct 1;19(19):5760-3. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.